MTS-108

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameMTS-108
Drug Alias NameMTS-108MTS108
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionDelta-like protein 3 bindersT cell surface glycoprotein CD3 modulators
TargetsDelta-like protein 3T cell surface glycoprotein CD3
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMetis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A